In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Arbutus Biopharma Corp (NASDAQ: ABUS) was $3.37 for the day, down -2.60% from the previous closing price of $3.46. In other words, the price has decreased by -$2.60 from its previous closing price. On the day, 1.31 million shares were traded.
Ratios:
Our analysis of ABUS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.02 and its Current Ratio is at 7.02. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 25, 2021, Jefferies started tracking the stock assigning a Hold rating and target price of $5.
On December 17, 2020, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.H.C. Wainwright initiated its Buy rating on December 17, 2020, with a $10 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 04 ’25 when HASTINGS DAVID C sold 22,183 shares for $3.28 per share. The transaction valued at 72,827 led to the insider holds 159,724 shares of the business.
Sims Karen sold 19,348 shares of ABUS for $63,519 on Feb 04 ’25. The Chief Medical Officer now owns 106,194 shares after completing the transaction at $3.28 per share. On Feb 04 ’25, another insider, McElhaugh Michael J., who serves as the Interim President & CEO of the company, sold 23,790 shares for $3.28 each. As a result, the insider received 78,103 and left with 1,481,003 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 94.75 while its Price-to-Book (P/B) ratio in mrq is 5.97.
Stock Price History:
Over the past 52 weeks, ABUS has reached a high of $4.72, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 1.20%, while the 200-Day Moving Average is calculated to be -6.10%.
Shares Statistics:
A total of 189.44M shares are outstanding, with a floating share count of 147.08M. Insiders hold about 22.38% of the company’s shares, while institutions hold 54.97% stake in the company.
